Company: CSTL
Filing Date: 2025-08-04
Form Type: 10-Q
Source: 0001447362-25-000097
Chunk: 118

Company: CASTLE BIOSCIENCES INC
Filing Date: 2025-08-04
Form: 10-Q
Item: Item 8
Chunk 118
---
 million and $4.5 million for the three and six months ended June 30, 2024 respectively.

8. Other Accrued and Current Liabilities

Other accrued and current liabilities consisted of the following (in thousands): June 30, 2025December 31, 2024Clinical studies$2,204 $2,580 Accrued service fees2,986 2,338 Accrued taxes1,193 1,076 ESPP Contributions969 1,225 Other869 774 Total$8,221 $7,993 

18

Table of ContentsCASTLE BIOSCIENCES, INC.NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)(UNAUDITED)

9. Long-Term Debt

Our long-term debt is presented in the table below (in thousands): June 30, 2025December 31, 2024Term debt$10,200 $10,200 Unamortized discount(160)(177)Total debt, net10,040 10,023 Less: Current portion of long-term debt(1,944)(278)Total long-term debt$8,096 $9,745 Future maturities of principal amounts on long-term debt as of June 30, 2025 were as follows (in thousands):Years Ending December 31,2025$278 20263,333 20273,333 20283,056 Total$10,000 2024 Loan and Security AgreementOn March 26, 2024 (the ‘‘Closing Date’’), we entered into a Loan and Security Agreement, as amended in April 2025 (the ‘‘2024 LSA”), by and between us, our wholly owned subsidiary, Castle Narnia Real Estate Holding 1, LLC and Silicon Valley Bank, a division of First-Citizens Bank & Trust Company (the “Lender’’). The 2024 LSA provides for (i) on the Closing Date, $10.0 million aggregate principal amount of term loans (discussed in the ‘‘2024 Term Loan’’ section below), and (ii) from the Closing Date until September 30, 2025, an additional line of credit of $25.0 million with the same interest rate and maturity as the term debt available (discussed in the ‘‘2024 Credit Line’’ section below)